Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Research & Development/Clinical Data - Sepsis Heidelberg (euro adhoc) - Planegg/Munich (Germany), Princeton, NJ and Houston, TX, January 17, 2011 - Agennix AG (Frankfurt Stock ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Mergers - Acquisitions - Takeovers Cologne, Heidelberg, Regensburg (euro adhoc) - Effective January 1, 2011 PROGEN Biotechnik GmbH, Heidelberg, and Multimetrix GmbH, Regensburg, both ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Research & Development/Severe Sepsis Heidelberg (euro adhoc) - Planegg/Munich (Germany), Princeton, NJ and Houston, TX, January 12, 2011 - Agennix AG (Frankfurt Stock Exchange: AGX) ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Research & Development Heidelberg (euro adhoc) - SYGNIS announces Data Safety Monitoring Board Recommendation for Phase II efficacy study for AX200 - more than 50% of the AXIS ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Capital measures Heidelberg (euro adhoc) - SYGNIS´ reduction of share capital in a 3:1 ratio was entered in the commercial register Heidelberg, 15 December 2010 - SYGNIS Pharma ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Company Information Heidelberg (euro adhoc) - Planegg/Munich (Germany), Princeton, NJ and Houston, TX, November 19, 2010 - Agennix AG (Frankfurt Stock Exchange: AGX) today announced that the Company will be presenting at two investor ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. 9-month report Heidelberg (euro adhoc) - Planegg/Munich (Germany), Princeton, NJ and Houston, TX, November 18, 2010 - Agennix AG (Frankfurt Stock Exchange: AGX) today announced ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. 6-month report Heidelberg (euro adhoc) - SYGNIS announces six month results of fiscal year 2010/2011 Heidelberg, 11 November 2010 - SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard) today published its ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Company Information Planegg/Munich (Germany), Princeton, NJ and Houston, TX (euro adhoc) - November 5, 2010 - Agennix AG (Frankfurt Stock Exchange (Prime Standard): AGX) today ...
Paris, November 5 (ots/PRNewswire) - Sanofi-aventis announced today that it is a partner in a new multidisciplinary atrial fibrillation research consortium, the "European Network for Translational research in Atrial Fibrillation" (EUTRAF), which has been awarded a EUR12 million grant to engage in atrial fibrillation (AF) research. The European consortium is ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Company Information Planegg/Munich (euro adhoc) - Planegg/Munich (Germany), November 4, 2010 - Agennix AG (Frankfurt Stock Exchange (Prime Standard): AGX/ISIN DE000A1A6XX4) was ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Litigation & Regulations 04.11.2010 Planegg/Munich (Germany), November 4, 2010 - Agennix AG (Frankfurt Stock ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Company Information 29.10.2010 Ad-hoc SYGNIS Pharma AG announces strategic restructuring Heidelberg, 29 October 2010 - SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard) announced today a ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. C.E.O. Interviews 28.10.2010 Ad-hoc Dr. Alfred Bach resigns as CEO of SYGNIS Pharma AG Heidelberg, 28 October 2010 - SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard) announced today that the ...
New: KRAS/BRAF Test for Luminex-User New: AmplideX FMR1 PCR-Assay Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. New Products/Research & Development/Distribution Subtitle: New: KRAS/BRAF Test for Luminex-User New: AmplideX FMR1 ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. 9-month report/Conference Call Heidelberg (euro adhoc) - Planegg/Munich (Germany), Princeton, NJ and Houston, TX, October 28, 2010 - Agennix AG (Frankfurt Stock Exchange: AGX) today ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Annual & Special Corporate Meetings Heidelberg (euro adhoc) - Press Release Heidelberg, October 20, 2010 - SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime ...
Collaboration in the field of Luminex xMAP® technology Segmentation of activities Exploitation of synergies Expansion of product range Development of new markets Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Joint ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Capital measures Heidelberg (euro adhoc) - Proceeds expected to enable Company to obtain topline data in Phase III non-small cell lung cancer trial with lead product candidate oral ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Offering 01.10.2010 Planegg/Munich (Germany), October 1, 2010 - Agennix AG (Frankfurt Stock Exchange (Prime ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Capital Increase; Supscription Price 15.09.2010 Planegg/Munich (Germany), September 15, 2010 - Agennix AG ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Research & Development/Severe Sepsis Heidelberg (euro adhoc) - Planegg/Munich (Germany), Princeton, NJ and Houston, TX, September 3, 2010 - Agennix AG (Frankfurt Stock Exchange: AGX) ...
Additional CE certified tests from PROGEN / Multimetrix for a two-step diagnostic of Lyme Borreliosis are approved for laboratory diagnosis Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. New Products Subtitle: Additional CE ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. 3-month report Heidelberg (euro adhoc) - Press release Heidelberg, August 12, 2010 - SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard) today reports financial results for the first quarter of the fiscal ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Financial Figures/Balance Sheet/6-month report Heidelberg (euro adhoc) - Agennix AG Reports Financial Results for Second Quarter and First Six Months of 2010 Planegg/Munich (Germany), Princeton, NJ and Houston, TX, August 5, 2010 - Agennix AG (Frankfurt Stock Exchange: AGX) today announced financial results for ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Research & Development Heidelberg (euro adhoc) - Agennix AG Provides Update on Development of Talactoferrin Planegg/Munich (Germany), Princeton, NJ and Houston, TX, August 5, 2010 - Agennix AG (Frankfurt Stock Exchange: AGX) today provided an update on its development status and plans for oral ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. 6-month report Heidelberg (euro adhoc) - Agennix AG Schedules Conference Call on August 5, 2010 to Discuss First Half of 2010 Financial Results Planegg/Munich (Germany), Princeton, NJ and Houston, TX, July 29, 2010 - Agennix AG (Frankfurt Stock Exchange: AGX) today announced that the Company will hold a conference call to discuss financial ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Loan agreement 23.07.2010 Agennix AG Secures E 15 Million Loan Planegg/Munich (Germany), Princeton, NJ and Houston, TX, July 23, 2010 - Agennix AG (Frankfurt Stock Exchange: AGX) today announced that it has entered into an agreement with one of its major shareholders, ...
Zürich (ots) - The Jacobs Foundation's Board of Trustees has appointed Dr. Auma Obama as a new member. Auma Obama works as a Global Technical Advisor for the aid organisation "CARE International" and - like the Jacobs Foundation - actively promotes educational and development opportunities for young people. The Jacobs Foundation, with its registered office in ...
Annual General Meeting 2010 to make regular decision on the composition of the Supervisory Board Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Annual & Special Corporate Meetings Subtitle: Annual General Meeting 2010 to make regular decision on the composition of the ...